down arrow

Aarti Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
675.60
49 (7.82%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.83 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Net Sales
1,013.52
898.15
988.55
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,013.52
898.15
988.55
Raw Material Cost
440.38
441.95
549.45
Purchase of Finished goods
185.04
83.85
157.58
(Increase) / Decrease In Stocks
-51.61
-2.64
-103.01
Employee Cost
76.96
64.85
61.70
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
172.61
137.28
147.01
Total Expenditure (Excl Depreciation)
823.39
725.29
812.73
Operating Profit (PBDIT) excl Other Income
190.13
172.86
175.82
Other Income
6.70
1.47
1.29
Operating Profit (PBDIT)
196.83
174.33
177.11
Interest
10.34
8.06
9.87
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
186.49
166.27
167.24
Depreciation
41.05
35.34
30.34
Profit Before Tax
145.44
130.92
136.90
Tax
35.37
32.03
33.97
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
110.08
98.89
102.93
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
110.08
98.89
102.93
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
110.08
98.89
102.93
Equity Capital
45.31
45.31
45.31
Face Value
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.15
10.91
11.36
Diluted Earnings per share
12.14
10.91
11.36
Operating Profit Margin (Excl OI)
18.76%
19.25%
17.79%
Gross Profit Margin
18.4%
18.51%
16.92%
PAT Margin
10.86%
11.01%
10.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 12.85% vs -9.14% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is 11.32% vs -3.92% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 9.99% vs -1.68% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is 28.29% vs -18.34% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has fallen from Sep 2023

Compare Half Yearly Results Of Aarti Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,013.52
5,969.93
-4,956.41
-83.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,013.52
5,969.93
-4,956.41
-83.02%
Raw Material Cost
440.38
934.97
-494.59
-52.90%
Purchase of Finished goods
185.04
857.27
-672.23
-78.42%
(Increase) / Decrease In Stocks
-51.61
-104.82
53.21
50.76%
Employee Cost
76.96
1,280.21
-1,203.25
-93.99%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
172.61
1,470.50
-1,297.89
-88.26%
Total Expenditure (Excl Depreciation)
823.39
4,438.13
-3,614.74
-81.45%
Operating Profit (PBDIT) excl Other Income
190.13
1,531.80
-1,341.67
-87.59%
Other Income
6.70
210.03
-203.33
-96.81%
Operating Profit (PBDIT)
196.83
1,741.83
-1,545.00
-88.70%
Interest
10.34
18.01
-7.67
-42.59%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
186.49
1,723.82
-1,537.33
-89.18%
Depreciation
41.05
213.36
-172.31
-80.76%
Profit Before Tax
145.44
1,510.46
-1,365.02
-90.37%
Tax
35.37
314.99
-279.62
-88.77%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
110.08
1,195.47
-1,085.39
-90.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
110.08
1,195.47
-1,085.39
-90.79%
Share in Profit of Associates
0.00
6.48
-6.48
-100.00%
Minority Interest
0.00
-11.99
11.99
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
110.08
1,189.96
-1,079.88
-90.75%
Equity Capital
45.31
40.06
5.25
13.11%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.15
29.70
-17.55
-59.09%
Diluted Earnings per share
12.14
29.65
-17.51
-59.06%
Operating Profit Margin (Excl OI)
18.76%
25.66%
0.00
-6.90%
Gross Profit Margin
18.40%
28.88%
0.00
-10.48%
PAT Margin
10.86%
20.13%
0.00
-9.27%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 1,013.52 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 12.85% vs -9.14% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 110.08 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 11.32% vs -3.92% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 190.13 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 9.99% vs -1.68% in Sep 2023

Half Yearly - Interest
Interest 10.34 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 28.29% vs -18.34% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.76%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has fallen from Sep 2023